GlassScriptPhysician profile
Jennifer M John
NPI 1447343140
$1,605.00
in general payments reported to CMS, 2019-2025
19 companies · $484 in 2025
The $484 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $94.05 · 2021: $62.68 · 2022: $228 · 2023: $347 · 2024: $389 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,220.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $232.85 | 2022-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.67 | 2021-2022 | |
| Amgen INC. | $190.24 | 2024-2025 | Tepezza, Prolia, Evenity |
| Insulet Corporation | $171.76 | 2022-2023 | Omnipod |
| Dexcom, INC. | $129.67 | 2023-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $119.87 | 2025 | Zepbound, Mounjaro |
| Xeris Pharmaceuticals, INC. | $103.39 | 2020-2025 | Gvoke Hypopen |
| Abbott Laboratories | $69.62 | 2024-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $67.85 | 2020 | |
| Beta Bionics, INC. | $58.95 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Mannkind Corporation | $51.91 | 2022-2025 | |
| Abbvie INC. | $43.28 | 2025 | |
| Intuity Medical INC | $38.12 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Genzyme Corporation | $36.10 | 2024 | |
| Ucb, INC. | $23.96 | 2025 | Bimzelx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $18.11 | 2025 | Xyosted |
| Medtronic, INC. | $17.85 | 2024 | Minimed 780g |
| Embecta Corp. | $17.54 | 2024 | |
| Medtronic Minimed, INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.